$6.68
0.7212.08%
Últ. Act.: Oct 9, 6:16 PM
$6.83
0.8714.6%
GT Biopharma (GTBP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.00 | $-2.00 | — | $-7.75 |
| Actual | $-3.00 | $-2.75 | $-121.00 | $-20.75 |
| Surprise | -50.0% | -37.5% | — | -167.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-2.50 | $-2.50 |
| Revenue | ||
| Consensus | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-3.00 | $-2.00 | -50.0 % |
| Q1 | May 15, 2026 | $-2.75 | $-2.00 | -37.5 % |
| Q3 | Nov 14, 2025 | $-20.75 | $-7.75 | -167.7 % |
| Q2 | Aug 14, 2025 | $-13.75 | $-17.00 | 19.1 % |